Ann: Next Science Investor Presentation May 2019, page-35

Re "they claim that their products are effective against the 80% of global bacterial infections that are associated with biofilm".

It's not a claim in the normal use of the word, it's a fact. It's also 90%, not 80%. So I can assure you that Next Science does have an effective answer to 90% of the problem.

FDA approvals via independent and blind Clinical trials are the highest hurdles in the global approval systems for medical innovations to be potentially marketed, more rigorous and stringent as I understand it, than CE Mark or TGA. An extract from p3 of the prospectus is:



Re "if Next Science does have an effective answer to antibiotic-resistant organisms then they have a Holy Grail."
Yes, they do have the answer to antibiotic-resistant organisms, including MRSA. I hope that you are right about it being the Holy Grail, for humanity's sake, as well as our successful investments!

From Page 6 of the prospectus: